ID
27903
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (3)
- 11/30/17 11/30/17 -
- 12/4/17 12/4/17 -
- 12/31/17 12/31/17 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 4, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Physical examination GOAL Trial B-cell Lymphoma NCT02499003
Physical examination GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Description
Physical examination
Description
Date
Data type
date
Description
General Appearance
Data type
text
Alias
- UMLS CUI [1]
- C1148438 (general appearance (physical finding))
Description
HEENT
Data type
text
Alias
- UMLS CUI [1,1]
- C1512338 (HEENT)
- LOINC
- LA16970-8
- UMLS CUI [1,2]
- C0031809 (Physical Examination)
- SNOMED
- 5880005
- LOINC
- MTHU028014
Description
Lung Thorax
Data type
text
Description
Cardiac examination
Data type
text
Description
Abdomen
Data type
text
Description
Extremities
Data type
text
Description
Muscosceletal examination
Data type
text
Description
Neurological examination
Data type
text
Description
Skin
Data type
text
Description
Lymph nodes
Data type
text
Description
Other region examination
Data type
text
Description
Other region
Data type
text
Similar models
Physical examination GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
No comments